Physician

Jaspreet Chahal, MD

According to 2025 Medicare claims, Jaspreet Chahal, MD (NPI: 1558703801) practices hematology/oncology in the Tucson, AZ market, with the plurality of this provider's patient population coming from Pima, AZ. This provider's primary affiliated billing organization is THE ONCOLOGY INSTITUTE CA, A PROFESSIONAL CORPORATION (NPI: 1689196719; TIN: 20-8366709) and primary practice location at 85710-3529. Chahal is affiliated with the ABC Network (ACO ID: A5554), participating under the MSSP model.

Chahal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 228 traditional Medicare patients, billed 89,366 HCPCS/CPT codes, and received $1,597,607 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 430 prescription claims across 135 beneficiaries totaling $672,431 in drug costs, led by Xarelto (Rivaroxaban). Open Payments data shows 142 records totaling $6,951. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $46,580 to $1,597,607. Similarly, Part D prescription costs have moved sharply higher in recent years, from $7,526 to $672,431. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$799K$1.6M2019 Medicare payment: $46,580 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $311,839 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $869,426 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $583,221 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $853,387 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,597,607 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019603,220$46,580
202015421,881$311,839
202123140,753$869,426
202221134,142$583,221
202321148,754$853,387
202422889,366$1,597,607

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$837K$1.7M2015 Drug cost: $7,526 (USD; Tot_Drug_Cst)2016 Drug cost: $16,898 (USD; Tot_Drug_Cst)2017 Drug cost: $100,480 (USD; Tot_Drug_Cst)2018 Drug cost: $226,491 (USD; Tot_Drug_Cst)2019 Drug cost: $338,713 (USD; Tot_Drug_Cst)2020 Drug cost: $555,928 (USD; Tot_Drug_Cst)2021 Drug cost: $1,647,605 (USD; Tot_Drug_Cst)2022 Drug cost: $1,300,341 (USD; Tot_Drug_Cst)2023 Drug cost: $1,674,852 (USD; Tot_Drug_Cst)2024 Drug cost: $672,431 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201555234$7,526
201650236$16,898
20172983$100,480
201831117$226,491
201976192$338,713
2020103429$555,928
2021178864$1,647,605
2022159574$1,300,341
2023139614$1,674,852
2024135430$672,431

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more107351$93
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more89123$64
J0897Injection, denosumab, 1 mg757,980$20
96372Injection of drug or substance under skin or into muscle87251$11
36415Insertion of needle into vein for collection of blood sample81188$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
XareltoRivaroxaban16900$16,748
EliquisApixaban15750$14,175
LetrozoleLetrozole232,005$610
MirtazapineMirtazapine231,060$542
Potassium ChloridePotassium Chloride24967$492

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.142$6,951SOBI, INC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jaspreet Chahal, MD?

Tedicare shows public-source Medicare data for Jaspreet Chahal, MD (NPI 1558703801), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jaspreet Chahal, MD have ACO affiliation data?

Jaspreet Chahal, MD is shown with ACO affiliation data for ABC Network (MSSP, ACO ID A5554).

What billing organization is linked to Jaspreet Chahal, MD?

Jaspreet Chahal, MD is linked to THE ONCOLOGY INSTITUTE CA, A PROFESSIONAL CORPORATION (billing NPI 1689196719) in the available physician profile data.

Does Jaspreet Chahal, MD have Open Payments data?

Jaspreet Chahal, MD has 142 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.